NAPSTIC2025-02-12 02:59:59Address：No. 15, Fuxing Road, Haidian District, Beijing, P.R. China, 100038adminSign in文章资讯Objective: To investigate the effect of intracoronary combined application of nitroprusside + recombinant human urokinase in patients with acute ST segment elevation myocardial infarction (STEMI) on the improvement of intracoronary artery reflow without reflow after emergency percutaneous coronary intervention (PCI) balloon dilation and opening. Methods: A total of 60 patients without reflow during STEMI emergency PCI admitted to the Department of Cardiology of Hebei Chest Hospital from March 2017 to March 2019 were selected as the research objects, and the patients were grouped by random number table method, with 30 cases in the observation group and 30 in the control group. The patients in the control group were treated with nitroprusside alone, and the patients in the observation group were treated with nitroprusside + recombinant human urokinase gen. The cardiac function parameters, blood flow classification of thrombolysis in myocardial infarction (TIMI), intraoperative and 24-hour postoperative bleeding, and the occurrence of major adverse cardiac events (MACE) within 1 month after surgery were analyzed and compared between the two groups. Results: After treatment, there were 28 (93.33%) and 20 (66.67%) patients in the observation group and the control group with TIMI blood flow grade 3, respectively, and the patients in the observation group were significantly better than the control group in terms of TIMI blood flow grading, and the difference was statistically significant (P<0.05). At 1 month after operation, the inner diameter of the left ventricular enddiastolic issue in the observation group was significantly lower than that in the control group 1 week after surgery, and was significantly lower than that of the control group. The left ventricular ejection fraction of the patients in the observation group was significantly higher than that in the control group at 1 week after operation, and the difference was statistically significant (P<0.05). The bleeding rates of the patients in the observation group and the control group were 16.67% (5/30) and 10.00% (3/30), respectively, and the incidence of MACE within 1 month after operation was 6.67% (2/30) and 20.00% (6/30), respectively, and there was no significant difference between the two groups (χ2= 0.144,P=0.704; χ2=2.401, P=0.254). Conclusion: The combined application of nitroprusside AND recombinant human urokinase gen in combination with intracoronary arterial therapy can effectively increase myocardial perfusion in patients without reflow during STEMI emergency PCI and improve cardiac function.10057
Zip code: 100038九宫排列法：解锁你的数字排列新技能九宫排列法，听起来像是某种神秘的魔法阵？而这其实是一种非常有趣且实用的数字排列方法。它可以帮助我们有效地组织和记忆复杂的数字序列，从游戏中的数字谜题到日常生活中的记账记录，它无所不在。今天，我们就来揭秘如何轻松运用九宫排列法，让你的逻...
